Pfizer CEO Expects Pivotal Coronavirus Vaccine Data in October

Albert Bourla, the CEO of Pfizer (NYSE:PFE), raised a lot of eyebrows on Thursday morning during a press briefing with biopharmaceutical industry executives leading efforts to develop vaccines and treatments to help mitigate the COVID-19 pandemic.